Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Spillane

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Practical Neurology|June 15, 2025
Neurological aspects of electrolyte disordersRobin S Howard, Aravindhan Baheerathan, Rachel Brown, et al.
BMJ Neurology Open|December 22, 2025
Robotic thymectomy for ocular myasthenia gravis: a case series from a UK tertiary centreThomas Roberts, Stephen Cone, Jennifer Spillane, et al.
Muscle & Nerve|January 10, 2026
Post Hoc, Sex-Specific Subgroup Analysis of Efgartigimod in Patients With Generalized Myasthenia Gravis From the ADAPT Trial: A Sex and Gender Equity in Research (SAGER) Guidelines ApproachSarah Hoffmann, Sihui Zhao, Filip Callewaert, et al.
Muscle & Nerve|January 3, 2013
Slow channel congenital myasthenic syndrome responsive to a combination of fluoxetine and salbutamolSarah Finlayson, Jennifer Spillane, Dimitri M Kullmann, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 7, 2012
Late recurrent thymoma in myasthenia gravis: a case seriesJennifer Spillane, Martin Hayward, Nicholas P Hirsch, et al.
Neurology|January 16, 2015
Lambert-Eaton syndrome IgG inhibits transmitter release via P/Q Ca2+ channelsJennifer Spillane, Yaroslav Ermolyuk, Marife Cano-Jaimez, et al.
The Cochrane Database of Systematic Reviews|April 8, 2025
Drug treatment for myotoniaJennifer Spillane, Jeroen Trip, Gea Drost, et al.
Journal of the Neurological Sciences|October 4, 2023
The Queen Square Encephalitis Multidisciplinary Team Meeting - experience over three years, pre and post the COVID-19 pandemicTehmina Bharucha, Rachel L Brown, Cristina Marcoci, et al.
Neurology|December 20, 2019
Thromboembolic risk with IVIg: Incidence and risk factors in patients with inflammatory neuropathyMahima Kapoor, Jennifer Spillane, Christina Englezou, et al.
The Cochrane Database of Systematic Reviews|July 8, 2025
Complement inhibitors for myasthenia gravis in adultsLaura M White, Fiona J Clay, Anne-Marie Forbes, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Practical Neurology|June 15, 2025
Neurological aspects of electrolyte disordersRobin S Howard, Aravindhan Baheerathan, Rachel Brown, et al.
BMJ Neurology Open|December 22, 2025
Robotic thymectomy for ocular myasthenia gravis: a case series from a UK tertiary centreThomas Roberts, Stephen Cone, Jennifer Spillane, et al.
Muscle & Nerve|January 10, 2026
Post Hoc, Sex-Specific Subgroup Analysis of Efgartigimod in Patients With Generalized Myasthenia Gravis From the ADAPT Trial: A Sex and Gender Equity in Research (SAGER) Guidelines ApproachSarah Hoffmann, Sihui Zhao, Filip Callewaert, et al.
Muscle & Nerve|January 3, 2013
Slow channel congenital myasthenic syndrome responsive to a combination of fluoxetine and salbutamolSarah Finlayson, Jennifer Spillane, Dimitri M Kullmann, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 7, 2012
Late recurrent thymoma in myasthenia gravis: a case seriesJennifer Spillane, Martin Hayward, Nicholas P Hirsch, et al.
Neurology|January 16, 2015
Lambert-Eaton syndrome IgG inhibits transmitter release via P/Q Ca2+ channelsJennifer Spillane, Yaroslav Ermolyuk, Marife Cano-Jaimez, et al.
The Cochrane Database of Systematic Reviews|April 8, 2025
Drug treatment for myotoniaJennifer Spillane, Jeroen Trip, Gea Drost, et al.
Journal of the Neurological Sciences|October 4, 2023
The Queen Square Encephalitis Multidisciplinary Team Meeting - experience over three years, pre and post the COVID-19 pandemicTehmina Bharucha, Rachel L Brown, Cristina Marcoci, et al.
Neurology|December 20, 2019
Thromboembolic risk with IVIg: Incidence and risk factors in patients with inflammatory neuropathyMahima Kapoor, Jennifer Spillane, Christina Englezou, et al.
The Cochrane Database of Systematic Reviews|July 8, 2025
Complement inhibitors for myasthenia gravis in adultsLaura M White, Fiona J Clay, Anne-Marie Forbes, et al.
Pageof 4